Israel’s Medial EarlySign (see here previously) has partnered US-based Geisinger to identify patients at high risk for respiratory or pulmonary diseases such as lung cancer. Their LungFlag AlgoMarker analyzes data from a patient’s electronic health record to enable early screening.
https://nocamels.com/2023/11/israeli-us-firms-create-ai-program-to-spot-lung-disease-risks/